Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02065817 · ClinicalTrials.gov registry record · NA
Dose of Labeled Cholesterol for Kinetics: A Pilot Study
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02065817: Completed NA study, sponsored by Mayo Clinic.
NCT02065817 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02065817, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This is a pilot study to determine the optimum time and dose to draw blood samples using a tracer for HDL kinetics.
Interventions
- OTHER stable isotope of cholesterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-02 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02065817
The ClinicalTrials.gov registry entry for NCT02065817 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which stable isotope of cholesterol is the first listed.
NCT02065817 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02065817 about?
NCT02065817 is a clinical study titled "Dose of Labeled Cholesterol for Kinetics: A Pilot Study". This is a pilot study to determine the optimum time and dose to draw blood samples using a tracer for HDL kinetics.
What is the current status of trial NCT02065817?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2014-02. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02065817?
The interventions under investigation include: stable isotope of cholesterol (OTHER).
Who is sponsoring clinical trial NCT02065817?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.